Unknown

Dataset Information

0

Use of Sotrovimab in 14 Children with COVID-19: A Single-center Experience.

ABSTRACT: Children affected by coronavirus disease 2019 (COVID-19) with preexisting comorbidities are at risk of complications. Monoclonal antibodies prevent severe COVID-19 courses in adults but data on children are scarce. Here we report on the use of Sotrovimab in 14 children at risk of severe disease treated at the University of Cologne Children's Hospital. Tolerability was good and no infusion-related reactions were seen.

SUBMITTER: Butzer SK 

PROVIDER: S-EPMC9935231 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Use of Sotrovimab in 14 Children with COVID-19: A Single-center Experience.

Butzer Sarina Kim SK   Habbig Sandra S   Mehler Katrin K   Haumann Sophie S   Meyer Meike M   Jung Norma N   Oberthür André A  

The Pediatric infectious disease journal 20221129 3

Children affected by coronavirus disease 2019 (COVID-19) with preexisting comorbidities are at risk of complications. Monoclonal antibodies prevent severe COVID-19 courses in adults but data on children are scarce. Here we report on the use of Sotrovimab in 14 children at risk of severe disease treated at the University of Cologne Children's Hospital. Tolerability was good and no infusion-related reactions were seen. ...[more]

Similar Datasets

Unknown Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Covid-19 - Single-Center Experience.
| S-EPMC10185933 | biostudies-literature
Unknown Post COVID-19 pulmonary complications; a single center experience.
| S-EPMC8578026 | biostudies-literature
Unknown The outcomes of children with primary malignant renal tumors: a 14-year single-center experience.
| S-EPMC11555868 | biostudies-literature
Unknown Cardiac pathology in COVID-19: a single center autopsy experience.
| S-EPMC8278836 | biostudies-literature
Unknown Electrodiagnostic findings in COVID-19 patients: A single center experience.
| S-EPMC8513511 | biostudies-literature
Unknown Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients.
| S-EPMC9214182 | biostudies-literature
Unknown Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience.
| S-EPMC7454852 | biostudies-literature
Unknown Challenges in heart transplantation during COVID-19: A single-center experience.
| S-EPMC7316040 | biostudies-literature
Unknown Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience.
| S-EPMC8950373 | biostudies-literature
Unknown A single center experience of intravenous immunoglobulin treatment in Covid-19.
| S-EPMC8200303 | biostudies-literature